Our lawyers represent pharmaceutical manufacturers, biotechnology companies, healthcare firms, investors, and other participants in the life sciences industry in disputes, investigations, transactions, and other significant matters affecting their businesses. The pharmaceutical and life sciences industries operate within one of the world's most complex legal and regulatory environments, where commercial disputes, regulatory obligations, government enforcement, and business strategy frequently intersect.
Our experience includes FDA inspections and Form 483 observations, Department of Justice and state attorney general investigations, False Claims Act matters, commercial litigation, and domestic and international arbitration. We have represented clients in disputes arising from mergers and acquisitions, licensing and co-promotion agreements, pharmaceutical products, audit rights, and capital-raising transactions. Our lawyers have also advised pre-revenue biotechnology and pharmaceutical companies on financing transactions, commercial agreements, capital formation, and other legal and strategic matters critical to their growth and development.
Legal issues in the life sciences industry rarely exist in isolation. A commercial dispute may carry regulatory consequences; an investigation may affect critical business relationships; and a transaction may implicate litigation, financing, or governance concerns. Whether responding to a government investigation, litigating a transaction-related dispute, handling an international arbitration, negotiating a commercial agreement, raising capital, or advising clients before disputes arise, we bring an understanding of both the legal issues and the commercial realities that shape our clients' decisions.
